The Effect of Major Depression on Sexual Function in Women

Journal of Sexual Medicine

Volumn 9, Issue 1, 2012, Pages 231-239

  Fabre, Louis F ^a   Smith, Louis C ^a  

^a Fabre Kramer Pharmaceuticals   (United States)

Author keywords

DSM IV Diagnoses of Sexual Disorders; Gepirone ER; HSDD; Hypoactive Sexual Desire Disorder; Treatment of Depression and Sexual Dysfunction

Indexed keywords

GEPIRONE;

ADULT; ARTICLE; ATYPICAL DEPRESSION; AVERSIVE BEHAVIOR; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FEMALE AROUSAL DISORDER; FEMALE ORGASMIC DISORDER; HAMILTON SCALE; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; ORGASM DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHIATRIST; SCORING SYSTEM; SELF REPORT; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SEXUAL HEALTH; WOMEN'S HEALTH;

EID: 84855348339     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02445.x     Document Type: Article

References (25)

1. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-44. Erratum in: JAMA 1999; 281:1174.
2. Moreira ED Jr, Brock G, Glasser DB, Nicolosi A, Laumann EO, Paik A, Wang T, Gingell C, GSSAB Investigators' Group. Help-seeking behaviour for sexual problems: The global study of sexual attitudes and behaviors. Int J Clin Pract 2005;59:6-16.
3. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol 1998;13(6 suppl):S1-4.
4. Bonierbale M, Lançon C, Tignol J. The ELIXIR study: Evaluation of sexual dysfunction in 4, 557 depressed patients in France. Curr Med Res Opin 2003;19:114-24.
5. Fava M, Dording CM, Baker RA, Mankoski R, Tran Q-V, Forbes RA, Eudicone JM, Owen R, Berman RM. Effects of adjunctive Aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: A post hoc analysis of 3 randomized, double-blind, placebo-controlled studies. Prim Care Companion CNS Disord 2011;13:e1-10.
6. Shindel AW, Eisenberg ML, Breyer BN, Sharlip ID, Smith JF. Sexual function and depressive symptoms among female North American medical students. J Sex Med 2011;8:391-9.
7. Patten SB. Accumulation of major depressive episodes over time in a prospective study indicates that retrospectively assessed lifetime prevalence estimates are too low. BMC Psychiatry 2009;9:19-23.
8. Montejo AL, Perahia DG, Spann ME, Wang F, Walker DJ, Yang CR, Detke MJ. Sexual function during long-term duloxetine treatment in patients with recurrent major depressive disorder. J Sex Med 2011;8:773-82.
9. Baldwin DS. Depression and sexual function. Br Med Bull 2001;57:81-99.
10. Clayton AH, McGarvey EL, Clavel GJ, Piazza L. Comparison of sexual functioning in clinical and non-clinical populations using the Changes in Sexual Function Questionnaire (CSFQ). Psychopharmacol Bull 1997;33:747-53.
11. Casper RC, Redmond DE Jr, Katz MM, Schaffer CB, Davis JM, Koslow SH. Somatic symptoms in primary affective disorder. Presence and relationship to the classification of depression. Arch Gen Psychiatry 1985;42:1098-104.
12. Kennedy SH, Dickens SE, Eisfeld BS, Bagby RM. Sexual dysfunction before antidepressant therapy in major depression. J Affect Disord 1999;56:201-8.
13. LF F, Smith LC, DeRogatis LR. The Effect of Major Depression on Sexual Function in Women as Measured by the DeRogatis Inventory of Sexual Function (DISF). Fourteenth ISSM World Meeting, Seoul, South Korea, September 26-30, 2010.
14. LF F, Smith LC, DeRogatis LR. "Differences in the Effect of Major Depression on Sexual Function of Men and Women" Fourteenth ISSM World Meeting, Seoul, South Korea, September 26-30, 2010.
15. American Psychiatry Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatry Association; 1994:496-8.
16. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
17. American Psychiatry Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, D.C.: American Psychiatry Association; 1994:384-6.
18. Camm AJ. The design and conduct of human studies to detect and quantify QT interval prolongation induced by new chemical entities. Fundam Clin Pharmacol 2002;16:141-5.
19. DeRogatis LR. The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): An introductory report. J Sex Marital Ther 1997;23:291-304.
20. Clayton AH, McGarvey EL, Clavet GJ. The Changes in Sexual Functioning Questionnaire (CSFQ): Development, reliability, and validity. Psychopharmacol Bull 1997;33:731-45.
21. Fabre LF, Smith LC, DeRogatis LR. Gepirone-ER treatment of low sexual desire associated with depression in women as measured by the Derogatis Inventory of Sexual Function (DISF) fantasy/cognition (desire) domain-A post hoc analysis. J Sex Med 2011 Jun 27 [Epub ahead of print] doi: 10.1111/j.1743-6109.2011.02330.x.
22. Clayton AH. The pathophysiology of hypoactive sexual desire disorder in women. Int J Gynaecol Obstet 2010;110:7-11.
23. McIntyre RS, Konarski JZ, Mancini DA, Zurowski M, Giacobbe P, Soczynska JK, Kennedy SH. Improving outcomes in depression: A focus on somatic symptoms. J Psychosom Res 2006;60:279-82.
24. Kennedy S. Flibanserin: Initial evidence of efficacy on sexual dysfunction, in patients with major depressive disorder. J Sex Med 2010;7:3449-59.
25. Fabre LF, Brown CS, Smith LC, Gepirone DLR. ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women. J Sex Med 2011;8:1411-9.